Pharmatizing AI

Digital

In this off-the-stage interview from Frontiers Health 2025 discover how 'pharmatized' AI delivers smarter, faster, and more reliable innovation.

News

Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.